Use of mTOR inhibitors for prevention of intestinal polyp growth and cancer
US12383538B2 · kind B2 · utility
0Cited by
169References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2021 |
| Grant date | Aug 12, 2025 |
| Priority date | — |
| Expiry date | Apr 13, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.